Hutchens & Kramer Investment Management Group LLC Sells 26 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hutchens & Kramer Investment Management Group LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 520 shares of the medical equipment provider’s stock after selling 26 shares during the period. Hutchens & Kramer Investment Management Group LLC’s holdings in Intuitive Surgical were worth $271,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth about $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 1.8 %

NASDAQ:ISRG opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a 50 day moving average of $547.16 and a 200 day moving average of $505.21. The stock has a market capitalization of $204.26 billion, a price-to-earnings ratio of 92.20, a PEG ratio of 5.19 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 42,265 shares of company stock valued at $21,964,281 over the last 90 days. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ISRG. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday. BTIG Research upped their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Finally, Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.